CVS (CVS)  recently announced plans to acquire Aetna (AET) for $69 billion in a move that is widely seen as an unprecedented merger of retail and healthcare.

But is the potential combo a reaction to Amazon's (AMZN) dive into healthcare? Amazon recently obtained wholesale distribution licenses from pharmaceutical boards in multiple states, including New Jersey, Connecticut, Michigan and Arizona. It's also reportedly in preliminary talks with generic drugmakers including Mylan NV and Sandoz (NVS) The question is, what will the master of disruption do next?

It's your move, Jeff Bezos. 

More of What's Trending on TheStreet:

 

N/A

More from Video

3 Things to Know at Market Close: Jamie Dimon's the King of Wall Street

3 Things to Know at Market Close: Jamie Dimon's the King of Wall Street

Striking Options: Crude Oil Volatility and Mixed Global Economic Data

Striking Options: Crude Oil Volatility and Mixed Global Economic Data

Jim Cramer's 10 Lessons for a Bear Market

Jim Cramer's 10 Lessons for a Bear Market

Does Davos Matter Anymore? Why Jim Cramer Says It Will Play Less of a Role

Does Davos Matter Anymore? Why Jim Cramer Says It Will Play Less of a Role

In Case You Missed it: Stocks Face Headwinds Times 10, IBM Earnings

In Case You Missed it: Stocks Face Headwinds Times 10, IBM Earnings